SCHEMBL21697640

SCHEMBL21697640

Brc1cc(Cc2cc3ccccc3s2)c(C2CC2)cc1OCc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGXT P21549 1/20 0.40
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
HTR1A P08908 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
CHRNA7 P36544 1/20 0.36
PTPN1 P18031 1/20 0.36
CCR5 P51681 1/20 0.36
SLC5A2 P31639 4/20 0.35
SLC5A1 P13866 2/20 0.35
ADRA1D P25100 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
PTGER1 P34995 1/20 0.35
HCRTR1 O43613 1/20 0.35
HCRTR2 O43614 1/20 0.35
ADRB2 P07550 1/20 0.34
CYP2A6 P11509 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16020849 0.84 CYP2A6 (0.36) AGXTSLC6A4CHRNA7SLC5A2SLC5A1
SCHEMBL21697633 0.83 SLC5A2 (0.40) AGXTHTR2AHTR2CSLC6A3SLC5A2
SCHEMBL20741882 0.83 CYP2A6 (0.40) AGXTHTR2AHTR2CPTPN1CCR5
SCHEMBL21697598 0.83 SLC5A2 (0.42) AGXTSLC5A2SLC5A1ADRA1DPTGER1
SCHEMBL20741835 0.82 SLC5A2 (0.44) AGXTPTPN1SLC5A2SLC5A1MEN1
SCHEMBL16018645 0.79 CYP2A6 (0.43) AGXTCHRNA7SLC5A2SLC5A1ADRA1D
SCHEMBL21697645 0.79 HTR2A (0.37) HTR2AHTR2CHTR1ASLC6A2SLC6A4
SCHEMBL21697625 0.78 AGXT (0.36) AGXTHTR2AHTR2CPTPN1SLC5A2
SCHEMBL20139432 0.75 HTR2A (0.45) HTR2AHTR2CHTR1ASLC6A2SLC6A4
SCHEMBL21697653 0.74 CYP2A6 (0.40) AGXTCHRNA7SLC5A2ADRA1DADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2968258-B1 DUAL SGLT1/SGLT2 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2020-02-12 EP disclosed